Empagliflozin and the Prevention of Heart Failure: Will Reverse Translation Lead to New Paradigms for the Treatment of Heart Failure?

Douglas L. Mann, Daniel P. Kelly

Research output: Contribution to journalEditorial

Fingerprint Dive into the research topics of 'Empagliflozin and the Prevention of Heart Failure: Will Reverse Translation Lead to New Paradigms for the Treatment of Heart Failure?'. Together they form a unique fingerprint.